Reference for ENSITRELVIR. Search for ENSITRELVIR

AI searches containing ENSITRELVIR

ENSITRELVIR

Ensitrelvir

COVID-19 SARS-CoV-2 3CL-protease-inhibitor antiviral drug

Ensitrelvir, sold under the brand name Xocova, is an antiviral medication used as a treatment for COVID-19 and as post-exposure prophylaxis (PEP) to prevent

Ensitrelvir

Post-exposure prophylaxis

Preventive medical treatment after exposure

the SARS-CoV-2 virus, it is no longer recommended for this purpose. Ensitrelvir has been studied for its potential use as post-exposure prophylaxis against

Post-exposure prophylaxis

Post-exposure_prophylaxis

COVID-19 drug development

Preventative and therapeutic medications for COVID-19 infection

changes were more common, especially where molnupiravir had been used. Ensitrelvir, sold under the brand name Xocova, is an antiviral medication used as

COVID-19 drug development

COVID-19_drug_development

Protease inhibitor (pharmacology)

Class of antiviral drugs used to treat HIV/AIDS and hepatitis C

acute respiratory syndrome coronavirus 2) inhibitors—class stem –trelvir Ensitrelvir Nirmatrelvir Simnotrelvir Given the specificity of the target of these

Protease inhibitor (pharmacology)

Protease_inhibitor_(pharmacology)

3C-like protease

Class of enzymes

12–18 were still covered under the EUA. The 3C-like protease inhibitor ensitrelvir received authorization to treat COVID-19 in Japan in 2022. In 2022, an

3C-like protease

3C-like_protease

List of antiviral drugs

Emtricitabine HIV Gilead Sciences NRTI 2003 Enfuvirtide HIV Entry inhibitor 2003 Ensitrelvir COVID-19 Shionogi 3C-like protease inhibitor Entecavir HIV NRTI 2005

List of antiviral drugs

List_of_antiviral_drugs

Shionogi

Japanese pharmaceutical company

treatment. Xofluza, an endonuclease inhibitor, for influenza treatment. Ensitrelvir, the first Japanese domestic pill to treat COVID-19. Asapiprant [Wikidata]

Shionogi

Galidesivir

Antiviral drug

Nelfinavir Oseltamivir Nirmatrelvir/ritonavir Peramivir Remdesivir Ribavirin Ensitrelvir TKM-Ebola Triazavirin Umifenovir ZMapp Warren TK, Wells J, Panchal RG

Galidesivir

List of drugs: Em–Ep

enrofloxacin (INN) Enropro Ensacove ensaculin (INN) ensartinib (USAN, INN) ensitrelvir (INN) ensituximab (USAN) Enspryng entacapone (INN) entecavir (INN) entinostat

List of drugs: Em–Ep

List_of_drugs:_Em–Ep

ATC code J05

Pharmaceutical drug classification

Fosamprenavir J05AE08 Atazanavir J05AE09 Tipranavir J05AE10 Darunavir J05AE11 Ensitrelvir J05AE30 Nirmatrelvir and ritonavir J05AF01 Zidovudine J05AF02 Didanosine

ATC code J05

ATC_code_J05

List of investigational long COVID drugs

Investigational long COVID drugs

antagonist) and atorvastatin (statin) [18] SFA-006 – GPR43 modulator [19] Ensitrelvir (S-217622; Xocova) – antiviral (coronavirus 3C-like proteinase inhibitor)

List of investigational long COVID drugs

List_of_investigational_long_COVID_drugs

COVID-19 pandemic in Nepal

Tixagevimab/cilgavimab Tocilizumab Small molecule antivirals Broad-spectrum Ensitrelvir Molnupiravir Co-packaged Nirmatrelvir ritonavir Variants Specific Alpha

COVID-19 pandemic in Nepal

COVID-19_pandemic_in_Nepal

Simeprevir

Chemical compound

Peginterferon alfa-2b# 3CL protease inhibitors (–trelvir) Atilotrelvir Ensitrelvir† Ibuzatrelvir Leritrelvir Lufotrelvir Nirmatrelvir† (+ritonavir)† Rupintrivir

Simeprevir